Bookmark
Forward
QuickView for Oxcarbazepine (compound)
PubChem
| Name: | oxcarbazepine |
|---|---|
| PubChem Compound ID: | 34312 |
| Molecular formula: | C15H12N2O2 |
| Molecular weight: | 252.268 g/mol |
| Synonyms: |
GP-47680; KBio2_007291; Oxcarbazepinum [INN-Latin]; Trileptal; Oxcarbazepine; KBio3_002677; Oxcarbazepina [INN-Spanish]; MLS000084586; C07492; Spectrum2_000483.
show more » |
DrugBank
Identification
| Name: | oxcarbazepine |
|---|---|
| Name (isomeric): | DB00776 |
| Drug Type: | small molecule |
| Synonyms: |
Oxcarbamazepine
|
| Brand: | Trileptal |
| Category: | Anticonvulsants |
| CAS number: | 28721-07-5 |
Pharmacology
| Indication: | For use as monotherapy or adjunctive therapy in the treatment of partial seizures in adults with epilepsy and as adjunctive therapy in the treatment of partial seizures in children ages 4-16 with epilepsy. |
|---|---|
| Pharmacology: |
Oxcarbazepine is structurally a derivative of carbamazepine, adding an extra oxygen atom to the benzylcarboxamide group. This difference helps reduce the impact on the liver of metabolizing the drug, and also prevents the serious forms of anemia occasionally associated with carbamazepine. Aside from this reduction in side effects, it is thought to ...
show more » |
| Mechanism of Action: |
The exact mechanism by which oxcarbazepine exerts its anticonvulsant effect is unknown. It is known that the pharmacological activity of oxcarbazepine occurs primarily through its 10-monohydroxy metabolite (MHD). In vitro studies indicate an MHD-induced blockade of voltage-sensitive sodium channels, resulting in stabilization of hyperexcited neuron...
show more » |
| Absorption: | Completely absorbed following oral administration. Food has no effect on the rate and extent of absorption of oxcarbazepine. |
| Protein binding: | Approximately 40% of the active 10-monohydroxy metabolite (MHD) is bound to serum proteins, predominantly to albumin. Neither oxcarbazepine nor its MHD binds with alpha-1–acid blycoprotein. |
| Biotransformation: | Oxcarbazepine is completely absorbed and extensively metabolized to its pharmacologically active 10-monohydroxy metabolite (MHD). MHD is metabolized further by conjugation with glucuronic acid. |
| Route of elimination: | Oxcarbazepine is cleared from the body mostly in the form of metabolites which are predominantly excreted by the kidneys. Fecal excretion accounts for less than 4% of the administered dose. |
| Half Life: | The half-life of the parent is about 2 hours, while the half-life of MHD is about 9 hours, so that MHD is responsible for most anti-epileptic activity. |
| Toxicity: | Isolated cases of overdose with oxcarbazepine have been reported. The maximum dose taken was approximately 24,000 mg. All patients recovered with symptomatic treatment. |
| Affected organisms: | Humans and other mammals |
Interactions
| Food interaction: |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug interaction: |
|
Targets
Enzymes
